Fig 2. Correlations between uremic solute concentrations and baseline covariates.

The square root of the pearson’s R² was taken to achieve positive values. The black symbols mark correlations that were statistically significant at a nominal p<0.05 after Bonferroni correction. DM: diabetes mellitus, Dx: congenital kidney disease, SBP: systolic blood pressure, DBP: diastolic blood pressure, eGFR: estimated GFR, Uprot: proteinuria, BMI: body mass index, chol: serum cholesterol, alb: serum albumin, ca: serum calcium, phos: serum phosphate, PTH: serum parathyroid hormone, UA: serum uric acid, RASi: renin-angiotensin inhibition, BPdrugs: blood pressure lowering drugs, anti-coag: anti-coagulation, VitD: vitamin D use, phos binder: phosphate binder use, statin: lipid lowerin drug use, ESA: erythropoiesis stimulating agent use, CMPF: 3-carboxy-4-methyl-5-propyl-2-furanpropionate, HA: hippuric acid, IAA: indole-3-acetic acid, IS: indoxyl sulfate, KYNA: kynurenic acid, KYN: kynurenine, QA: quinolinic acid, PCG: p-cresyl glucuronide, PCS: p-cresyl sulfate, PHS: phenyl sulfate, TRP: tryptophan, prot intake: dietary protein intake, sat fatty acid: saturated fatty acid intake, MU fatty acid: mono unsaturated fatty acid intake, PU fatty acid: poly unsaturated fatty acid intake, carb intake: carbohydrate intake, % fat: proportion of fat in diet, % protein: proportion protein in diet, % carbs: proportion carbohydrates in diet, % unsat fat: proportion of poly unsaturated fatty acids of total fatty acid intake.